Sara Bonstein
Director of Finance/CFO bij INSMED INCORPORATED
Vermogen: 3 M $ op 31-03-2024
Actieve functies van Sara Bonstein
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INSMED INCORPORATED | Director of Finance/CFO | 31-01-2020 | - |
| SCPHARMACEUTICALS INC. | Director/Board Member | 08-07-2020 | - |
| Independent Dir/Board Member | 08-07-2020 | - | |
| XILIO THERAPEUTICS, INC. | Director/Board Member | 17-08-2021 | - |
| Independent Dir/Board Member | 17-08-2021 | - |
Loopbaan van Sara Bonstein
Eerdere bekende functies van Sara Bonstein
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Chief Operating Officer | 01-05-2018 | 30-01-2020 |
| Director of Finance/CFO | 01-05-2018 | 30-01-2020 | |
| Corporate Secretary | 01-05-2018 | 30-01-2020 | |
| AYALA PHARMACEUTICALS, INC. | Director of Finance/CFO | 01-02-2014 | 30-04-2018 |
| Corporate Secretary | 01-02-2014 | 30-04-2018 | |
| Treasurer | 01-02-2014 | 30-04-2018 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01-08-2004 | 01-02-2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Opleiding van Sara Bonstein
| The College of New Jersey | Undergraduate Degree |
| Rider University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 10 |
Operationeel
| Director of Finance/CFO | 3 |
| Corporate Secretary | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 3 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| INSMED INCORPORATED | Health Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| SCPHARMACEUTICALS INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Beurs
- Insiders
- Sara Bonstein
- Ervaring
